论文部分内容阅读
目的观察脑苷肌肽联合路路通治疗脑梗死的疗效。方法将132例脑梗死患者随机分为治疗组和对照组,治疗组用脑苷肌肽注射液16mL,路路通注射液30mL每天1次,2w为1个疗程。并采用NIHSS对患者治疗前、后的疗效进行评定。结果治疗组神经功能缺损评分降低明显优于对照组(P<0.05)。结论脑苷肌肽联合路路通对提高患者生存质量,促进脑功能恢复和改善预后具有较好的疗效。
Objective To observe the therapeutic effect of cerebroside and carprostadil on cerebral infarction. Methods 132 patients with cerebral infarction were randomly divided into treatment group and control group. The treatment group received 16 mL of CGM injection and 30 mL of LLL injection once daily, and the course of treatment was 2 weeks. NIHSS was used to assess the efficacy of the treatment before and after treatment. Results The neurological deficit score of the treatment group was significantly lower than that of the control group (P <0.05). Conclusion Cerebroside combined with carpirudin can improve the quality of life, promote the recovery of brain function and improve prognosis.